Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer
ClinicalTrials.gov study NCT05472506. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)
ClinicalTrials.gov study NCT05357846. IPD Sharing: NO. Countries: 1. Publications: 0.
Neural Mechanisms and Clinical Applications of DBS for Modulating Sleep Dysregulation in PD
ClinicalTrials.gov study NCT06914466. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Anti PD-1 Therapy in Children, Adolescents and Young Adults (CAYA) Melanoma Patients
ClinicalTrials.gov study NCT06281912. IPD Sharing: NO. Countries: 7. Publications: 0.
A Study of ICP-189 and ICP-189 in Combination With Anti-PD-1 Monoclonal Antibody in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT05370755. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
ClinicalTrials.gov study NCT05264974. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04393220. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM
ClinicalTrials.gov study NCT03907202. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
PK, PD, Safety & Immunogenicity of ADL-018 Lyo in Healthy Adult Subjects
ClinicalTrials.gov study NCT05564611. IPD Sharing: NO. Countries: 1. Publications: 0.
A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199
ClinicalTrials.gov study NCT03880487. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT04997850. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
ClinicalTrials.gov study NCT06288360. IPD Sharing: NO. Countries: 1. Publications: 0.
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
ClinicalTrials.gov study NCT05718323. IPD Sharing: YES. Countries: 4. Publications: 0.
Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD)
ClinicalTrials.gov study NCT04565080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers
ClinicalTrials.gov study NCT05132803. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis
ClinicalTrials.gov study NCT00763503. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease
ClinicalTrials.gov study NCT06859528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
ClinicalTrials.gov study NCT05125055. IPD Sharing: YES. Countries: 1. Publications: 0.
Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate
ClinicalTrials.gov study NCT04059874. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Safety, Tolerability and PK, PD of HPG1860 in Healthy Subjects
ClinicalTrials.gov study NCT04480697. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.